Description

Letrozole, also known by its trade name Fermara, is a highly selective and very potent third-generation non-steroidal aromatase inhibitor. This drug was initially developed as an antineoplastic agent and is commonly used in the treatment of estrogen-dependent breast tumors.

In men, letrozole (Fermara) is used to reduce the concentration of estrogen in the blood and promote an increase in endogenous testosterone and gonadotropin hormone levels. Its mechanism of action is based on the inhibition of the aromatase enzyme, which is responsible for converting testosterone into estrogen. An excess of estrogen can have negative effects on the central nervous system and hypothalamus, reducing LH secretion and, consequently, testosterone production.

It is important to note that letrozole does not directly eliminate estradiol already present in high quantities, but prevents the formation of new estrogen, helping to stabilize hormonal balance.

---

Purpose of use

In bodybuilding and strength sports, Fermara (letrozole) is mainly used during anabolic steroid cycles. Not all AAS are subject to aromatization, but letrozole is particularly recommended when using substances such as testosterone and its derivatives (methandrostenolone, methyltestosterone, etc.).

It should be remembered that moderate levels of estrogen are physiologically beneficial for muscle growth, libido, and overall well-being. For this reason, letrozole should be used in controlled doses, avoiding excessive estrogen suppression.

---

How to use

The most rational approach involves regular monitoring of estradiol:

• every 10–14 days with short half-life steroids (e.g., testosterone propionate, methandrostenolone)

• after 3–4 weeks with long esters (enantate, cypionate, Sustanon)

The average starting dose of letrozole is 0.25 mg daily or every other day. After approximately 10 days, it is advisable to perform a new estradiol test and adjust the dosage based on the results.

It is known that very low doses (around 0.02 mg) can already reduce estrogen levels by about a third. Thanks to its long half-life, letrozole can also be taken every other day.

---

Dosage

A 1 mg dose of letrozole can reduce blood estradiol levels by approximately 80%, reaching over 98% in experimental studies.
Fermara is typically used starting at 1 mg every other day; in cases of marked aromatization, the frequency may be increased. The optimal dosage should always be determined based on blood tests.

---

Pharmacokinetic profile

• Half-life: 3–4 days

• Frequency of intake: once every 1–5 days

---

Main effects

• prevention of gynecomastia

• increase in anabolic hormone levels

• improved muscle definition (by reducing estrogenic effects)

• support in the prevention ofestrogen-related hypertension

• reduction in estrogen suppression of the hypothalamic-pituitary-testicular axis, promoting faster recovery

---

Possible side effects

• possible inhibition of muscle growth if estrogen is suppressed excessively

• arthralgia (joint pain)

• decrease in bone density

• changes in lipid profile (increased cholesterol)

• decreased libido

• deterioration in overall well-being

• depressive symptoms

---

Storage

• keep out of reach of children

• store in a cool, dry place

• protect from direct sunlight

• store at room temperature

• Do not use after the expiration date.